Breakthrough Invasive Fungal Infections in Pediatric Acute Myeloid and Lymphoblastic Leukemia Receiving Mold-active Prophylaxis
Despite mold-active antifungal prophylaxis, nearly one-third of pediatric leukemia patients developed IFIs, with high mortality in probable and proven cases. The predominance of breakthrough mold infections underscores the limitations of current prophylactic strategies. Optimized prophylaxis, therapeutic drug monitoring and early diagnostic approaches are urgently needed to reduce the burden of IFIs in this high-risk population.
Authors
- turan bayhan
- F. Nur Ünal (ORCID: https://orcid.org/0000-0002-1887-8968)
- Hatice Kübra Konca (ORCID: https://orcid.org/0000-0002-7235-4217)
- Özlem Arman
- Seval Çevik Özen
- Aysun Yahşi
- Belgin Gülhan
- Nese Yarali
- TUĞBA ERAT
- GÜLSÜM İCLAL BAYHAN
- Namik Yasar Ozbek
Institutions
- Ministry of Health (TR)
- Bilkent University (TR)
- University of Health Science (KH)
- Sağlık Bilimleri Üniversitesi (TR)
- Ankara Yıldırım Beyazıt University (TR)
Publication Details
- Journal
- The Pediatric Infectious Disease Journal
- Published
- 2026-03-03
- DOI
- https://doi.org/10.1097/inf.0000000000005196
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00